Syn NL - Search Results

1

Biopharmacological considerations for accelerating drug development of deguelin, a rotenoid with potent chemotherapeutic and chemopreventive potential.

Varughese RS, Lam WS, Marican AABH, Viganeshwari SH, Bhave AS, Syn NL, Wang J, Wong AL, Kumar AP, Lobie PE, Lee SC, Sethi G, Goh BC, Wang L. Varughese RS, et al. Among authors: syn nl. Cancer. 2019 Jun 1;125(11):1789-1798. doi: 10.1002/cncr.32069. Epub 2019 Apr 1. Cancer. 2019. PMID: 30933320 Free article. Review.

2

Exosome-Mediated Metastasis: From Epithelial-Mesenchymal Transition to Escape from Immunosurveillance.

Syn N, Wang L, Sethi G, Thiery JP, Goh BC. Syn N, et al. Trends Pharmacol Sci. 2016 Jul;37(7):606-617. doi: 10.1016/j.tips.2016.04.006. Epub 2016 May 3. Trends Pharmacol Sci. 2016. PMID: 27157716 Review.

3

Pharmacogenetics-Guided Phase I Study of Capecitabine on an Intermittent Schedule in Patients with Advanced or Metastatic Solid Tumours.

Soo RA, Syn N, Lee SC, Wang L, Lim XY, Loh M, Tan SH, Zee YK, Wong AL, Chuah B, Chan D, Lim SE, Goh BC, Soong R, Yong WP. Soo RA, et al. Sci Rep. 2016 Jun 14;6:27826. doi: 10.1038/srep27826. Sci Rep. 2016. PMID: 27296624 Free PMC article. Clinical Trial.

4

Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges.

Syn NL, Wang L, Chow EK, Lim CT, Goh BC. Syn NL, et al. Trends Biotechnol. 2017 Jul;35(7):665-676. doi: 10.1016/j.tibtech.2017.03.004. Epub 2017 Mar 29. Trends Biotechnol. 2017. PMID: 28365132 Review.

5

Immune checkpoint inhibitors in epidermal growth factor receptor mutant non-small cell lung cancer: Current controversies and future directions.

Soo RA, Lim SM, Syn NL, Teng R, Soong R, Mok TSK, Cho BC. Soo RA, et al. Among authors: syn nl. Lung Cancer. 2018 Jan;115:12-20. doi: 10.1016/j.lungcan.2017.11.009. Epub 2017 Nov 13. Lung Cancer. 2018. PMID: 29290252 Review.

6

Acquired resistance to EGFR targeted therapy in non-small cell lung cancer: Mechanisms and therapeutic strategies.

Lim SM, Syn NL, Cho BC, Soo RA. Lim SM, et al. Among authors: syn nl. Cancer Treat Rev. 2018 Apr;65:1-10. doi: 10.1016/j.ctrv.2018.02.006. Epub 2018 Feb 20. Cancer Treat Rev. 2018. PMID: 29477930 Review.

7

Resisting resistance to cancer immunotherapy.

Lam WS, Wang LZ, Roudi R, Yong WP, Syn NL, Sundar R. Lam WS, et al. Among authors: syn nl. Thorac Cancer. 2018 May;9(5):507-508. doi: 10.1111/1759-7714.12614. Epub 2018 Mar 7. Thorac Cancer. 2018. PMID: 29512891 Free PMC article. No abstract available.

8

Pan-CDK inhibition augments cisplatin lethality in nasopharyngeal carcinoma cell lines and xenograft models.

Syn NL, Lim PL, Kong LR, Wang L, Wong AL, Lim CM, Loh TKS, Siemeister G, Goh BC, Hsieh WS. Syn NL, et al. Signal Transduct Target Ther. 2018 Apr 13;3:9. doi: 10.1038/s41392-018-0010-0. eCollection 2018. Signal Transduct Target Ther. 2018. PMID: 29666673 Free PMC article.

9

Discovering novel SNPs that are correlated with patient outcome in a Singaporean cancer patient cohort treated with gemcitabine-based chemotherapy.

Limviphuvadh V, Tan CS, Konishi F, Jenjaroenpun P, Xiang JS, Kremenska Y, Mu YS, Syn N, Lee SC, Soo RA, Eisenhaber F, Maurer-Stroh S, Yong WP. Limviphuvadh V, et al. BMC Cancer. 2018 May 11;18(1):555. doi: 10.1186/s12885-018-4471-x. BMC Cancer. 2018. PMID: 29751792 Free PMC article. Clinical Trial.

10

Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial.

Syn NL, Wong AL, Lee SC, Teoh HL, Yip JWL, Seet RC, Yeo WT, Kristanto W, Bee PC, Poon LM, Marban P, Wu TS, Winther MD, Brunham LR, Soong R, Tai BC, Goh BC. Syn NL, et al. BMC Med. 2018 Jul 10;16(1):104. doi: 10.1186/s12916-018-1093-8. BMC Med. 2018. PMID: 29986700 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

242 results

Search Page